Viatris to contribute its biosimilars portfolio to Biocon Biologics for up to $3.335 billion, shares jump 4% premarket Finances February 28, 2022 [ad_1] Viatris Inc. VTRS, +4.38%, the corporate fashioned by the merger of Mylan and Pfizer Inc. PFE, +3.83% unit Upjohn…
